Collaborate Disseminate
A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the prima… Continue reading First head-to-head trial pits psychedelic therapy against antidepressant
New research from scientists at Stanford University School of Medicine suggests cannabis use can be linked to higher rates of “rebound headaches” in migraine sufferers. The research is observational and retrospective, but it is yet another finding ques… Continue reading Cannabis use linked to more rebound headaches in migraine sufferers
A first of its kind “self-blinded” trial testing the effect of psychedelic microdosing has found the anecdotally popular practice may be an example of a strong placebo effect. The research, led by Imperial College London, suggests there is little diffe… Continue reading First-of-its-kind trial finds psychedelic microdosing is equal to placebo
A new study published in the Journal of Psychopharmacology is reporting on a landmark clinical trial exploring the potential for MDMA-assisted psychotherapy in treating subjects with alcohol use disorder. The small open-label trial is the first to test… Continue reading MDMA proves a promising alcoholism treatment in world-first trial
A broad drug reform bill has been introduced to the California state legislature proposing to decriminalize the possession and personal use of a number of psychedelic drugs, including LSD, psilocybin and MDMA. The bill proposes to expunge all criminal … Continue reading California bill proposes lawful use and sharing of psychedelic drugs
Cannabidiol, better known as CBD, is rapidly gaining popularity as a potion to treat almost every kind of medical concern you can think of, but scientific evidence is scant outside of a few clinically proven indications. A new study from a team of Cana… Continue reading Clinical trial finds CBD does not help cocaine addicts kick the habit
A novel Australian trial is set to investigate the popular yet still deeply unproven practice of microdosing psychedelics. The research promises to be the first exploration of naturalistic psilocybin microdosing in a lab-setting using a cutting-edge ne… Continue reading Unique magic mushroom microdosing study to begin in Australia
A novel Australian trial is set to investigate the popular yet still deeply unproven practice of microdosing psychedelics. The research promises to be the first exploration of naturalistic psilocybin microdosing in a lab-setting using a cutting-edge ne… Continue reading Unique magic mushroom microdosing study to begin in Australia
A team of Australian scientists has demonstrated a novel microencapsulation method designed to improve the absorption and bioavailability of cannabidiol (CBD). Animal tests suggest the new method increases peak concentrations of CBD in the brain by 300… Continue reading New microcapsule method boosts CBD absorption in the brain by 300%
Surfing the wave of novel research into medical uses for psychedelic compounds, the Icahn School of Medicine at Mount Sinai has launched a dedicated psychedelic center focusing initially on the study of MDMA and psilocybin for PTSD and other stress-rel… Continue reading Psychedelic research center launched at New York’s Mount Sinai